Frank Azzopardi
Lawyers
Filters
Uber Technologies $900 million senior notes offering
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering by Uber Technologies, Inc. of $900 million aggregate principal amount of…
Alector $150 million at-the-market offering
Davis Polk advised the sales agents in connection with an SEC-registered at-the-market offering by Alector, Inc. of shares of its common stock for up to a maximum offering price of …
Revlon BrandCo $815 million financing
We are advising Revlon’s BrandCo lenders
Lam Research $2 billion notes offering
Davis Polk advised the joint book-running managers in connection with a $2 billion SEC-registered notes offering by Lam Research Corporation, consisting of $750 million aggregate…
NeoGenomics $300 million offerings of stock and convertible senior notes
Davis Polk advised the joint book-running managers in connection with concurrent SEC-registered offerings by NeoGenomics, Inc. of 4,400,000 shares of its common stock and $175 million…
SS&C Technologies $120 million acquisition of Innovest Systems
Davis Polk is advising SS&C Technologies Holdings, Inc. on its $120 million acquisition of Innovest Systems, LLC. The transaction is expected to close in the second quarter of 2020.
SS…
Constellation Brands $1.2 billion senior notes offering
Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering by Constellation Brands, Inc. of $600 million aggregate principal amount of…
Inphi $506 million convertible senior notes offering
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Inphi Corporation of $506 million aggregate principal amount of its 0.75%…
DXC Technology $1 billion senior notes offering
Davis Polk advised the representatives of the several underwriters in connection with the registered offering by DXC Technology Company of $500 million aggregate principal amount of 4.000%…
Coherus BioSciences $200 million convertible notes offering
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Coherus BioSciences, Inc. of $200 million aggregate principal amount of its…